WEE1 inhibition in pancreatic cancer cells is dependent on DNA repair status in a context dependent manner.

WEE1 inhibition in pancreatic cancer cells is dependent on DNA repair status in a context dependent manner.

Item
http://www.wikidata.org/entity/Q41063971
Pharmacotherapeutic Management of Pancreatic Ductal Adenocarcinoma: Current and Emerging Concepts.MEK inhibitors cobimetinib and trametinib, regressed a gemcitabine-resistant pancreatic-cancer patient-derived orthotopic xenograft (PDOX)Mutational status of TP53 defines the efficacy of Wee1 inhibitor AZD1775 in KRAS-mutant non-small cell lung cancer.Elevated HuR in Pancreas Promotes a Pancreatitis-like Inflammatory Microenvironment that Facilitates Tumor Development.Directing the use of DDR kinase inhibitors in cancer treatment.CRISPR Knockout of the HuR Gene Causes a Xenograft Lethal Phenotype.Augmentation of the therapeutic efficacy of WEE1 kinase inhibitor AZD1775 by inhibiting the YAP-E2F1-DNA damage response pathway axis.Augmented antitumor activity by olaparib plus AZD1775 in gastric cancer through disrupting DNA damage repair pathways and DNA damage checkpoint.
P2860

WEE1 inhibition in pancreatic cancer cells is dependent on DNA repair status in a context dependent manner.

Item
http://www.wikidata.org/entity/Q41063971
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
WEE1 inhibition in pancreatic ...... in a context dependent manner.
@en
type
label
WEE1 inhibition in pancreatic ...... in a context dependent manner.
@en
prefLabel
WEE1 inhibition in pancreatic ...... in a context dependent manner.
@en
P1433
P1476
P2093
P2860
P2888
P304
P31
P356
P407
P478
P50
P577
P698
P932
P356
P1433
P1476
WEE1 inhibition in pancreatic ...... in a context dependent manner.
@en
P2093
P2860
P2888
P304
P31
P356
P407
P478
P50
P577
P698
P932